Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site, Randomized, Parallel-Arm, Midazolam-Controlled, Clinical Trial

被引:0
|
作者
Murrough, James W. [1 ]
机构
[1] Mt Sinai Sch Med, New York, NY USA
关键词
Ketamine; major depression; treatment resistant; glutamate; antidepressant;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
442
引用
收藏
页码:142S / 142S
页数:1
相关论文
共 50 条
  • [1] Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
    Murrough, James W.
    Losifescu, Dan V.
    Chang, Lee C.
    Al Jurdi, Rayan K.
    Green, Charles E.
    Perez, Andrew M.
    Lqbal, Syed
    Pillemer, Sarah
    Foulkes, Alexandra
    Shah, Asim
    Charney, Dennis S.
    Mathew, Sanjay J.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (10): : 1134 - 1142
  • [2] Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site, randomised controlled trial
    Murrough, J. W.
    Iosifescu, D. V.
    Chang, L.
    Al Jurdi, R. K.
    Green, C.
    Perez, A.
    Iqbal, S. Z.
    Pillemer, S.
    Foulkes, A.
    Mathew, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S411 - S412
  • [3] Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial
    Dwyer, Jennifer B.
    Landeros-Weisenberger, Angeli
    Johnson, Jessica A.
    Tobon, Amalia Londono
    Flores, Jose M.
    Nasir, Madeeha
    Couloures, Kevin
    Sanacora, Gerard
    Bloch, Michael H.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (04): : 352 - 362
  • [4] Ketamine in Adolescent Treatment-Resistant Depression: Secondary Outcomes of a Randomized, Midazolam-Controlled Trial
    Dwyer, Jennifer
    Sanacora, Gerard
    Bloch, Michael
    [J]. NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 109 - 109
  • [5] Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
    Grunebaum, Michael F.
    Galfalvy, Hanga C.
    Choo, Tse-Hwei
    Keilp, John G.
    Moitra, Vivek K.
    Parris, Michelle S.
    Marver, Julia E.
    Burke, Ainsley K.
    Milak, Matthew S.
    Sublette, M. Elizabeth
    Oquendo, Maria A.
    Mann, J. John
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2018, 175 (04): : 327 - 335
  • [6] Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial
    Grunebaum, Michael F.
    Ellis, Steven P.
    Keilp, John G.
    Moitra, Vivek K.
    Cooper, Thomas B.
    Marver, Julia E.
    Burke, Ainsley K.
    Milak, Matthew S.
    Sublette, M. Elizabeth
    Oquendo, Maria A.
    Mann, J. John
    [J]. BIPOLAR DISORDERS, 2017, 19 (03) : 176 - 183
  • [7] Online mindfulness-based cognitive therapy for treatment-resistant depression: a parallel-arm randomized controlled feasibility trial
    Rodrigues, Michele Ferreira
    Quagliato, Laiana
    Appolinario, Jose Carlos
    Nardi, Antonio E.
    [J]. FRONTIERS IN PSYCHOLOGY, 2024, 15
  • [8] A Randomized Controlled Trial of Ketamine for Adolescent Treatment-Resistant Depression
    Dwyer, Jennifer
    Yip, Sarah
    Sanacora, Gerard
    Bloch, Michael
    [J]. NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S95 - S95
  • [9] A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation
    Su, Tung-Ping
    Li, Cheng-Ta
    Lin, Wei-Chen
    Wu, Hui-Ju
    Tsai, Shih-Jen
    Bai, Ya-Mei
    Mao, Wei-Chung
    Tu, Pei-Chi
    Chen, Li-Fen
    Li, Wei-Chi
    Chen, Mu-Hong
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2023, 26 (05): : 331 - 339
  • [10] Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
    Murrough, James W.
    Burdick, Katherine E.
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Chang, Lee C.
    Foulkes, Alexandra
    Charney, Dennis S.
    Mathew, Sanjay J.
    Iosifescu, Dan V.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 (05) : 1084 - 1090